The small GTPases of the Rac/Rho/Cdc42 subfamily are implicated in actin cytoskeleton-membrane interaction in mammalian cells and budding yeast. The in vivo functions of these GTPases in multicellular organisms are not known. We have cloned Drosophila homologs of rac and CDC42, Dracl, and Dcdc42. They share 70% amino acid sequence identity with each other, and both are highly expressed in the nervous system and mesoderm during neuronal and muscle differentiation, respectively. We expressed putative constitutively active and dominant-negative Dracl proteins in these tissues. When expressed in neurons, Dracl mutant proteins cause axon outgrowth defects in peripheral neurons without affecting dendrites. When expressed in muscle precursors, they cause complete failure of, or abnormality in, myoblast fusion. Expressions of analogous mutant Dcdc42 proteins cause qualitatively distinct morphological defects, suggesting that similar GTPases in the same subfamily have unique roles in morphogenesis.
In Drosophila, genetic screens to isolate mutations have yielded much insight into the organization of body plan (Niisslein-Volhard and Wieschaus 1980) and the specification of cell fate (for review, see Rubin 1991; Ghysen et al. 1993) . The same approach has been applied to isolate mutations affecting axon guidance (Seeger et al. 1993; Van Vactor et al. 1993) . In general, for later developmental processes, such a strategy may face several complexities. For genes that are required at multiple times and in multiple places, a mutant phenotype of the first developmental defect may mask later phenotypes. Defects in multiple tissues also make it difficult to distinguish the cause from the effect.
We are interested in identifying genes involved in neuronal morphogenesis. One strategy is to create dominant mutations in candidate genes and to express them in a temporal and tissue-specific manner, as described by Brand and Perrimon (1993) . We have explored the possibility that aspects of neuronal morphogenesis such as axonal and dendritic outgrowth may share similar molecular mechanisms as the budding of yeast Saccharomyces cerevisiae. From a cell biological point of view, both processes are brought about via polarized secretion and plasma membrane addition.
Genetic analysis of yeast budding has divided this complex process into two major steps consisting of bud site selection and bud site assembly Drubin 1991) . Small GTPases of the Ras superfamily (Bender and Pringle 1989; Johnson and Pringle 1990) , their associated guanine nucleotide exchange factors Hart et al. 1991; Powers et al. 1991; Ron et al. 1991) , and GTPase-activating proteins (GAP) (Park et al. 1993 ) play prominent roles in both events. In particular, the Cdc42 protein product is essential for bud site assembly (Johnson and Pringle 1990) . A human Cdc42 homolog has been identified (Shinjo et al. 1990 ), yet the function of Cdc42 in multicellular organisms is unknown. Cdc42 belongs to the same GTPase subfamily as the proteins Rac and Rho, which have been implicated in membrane-actin cytoskeleton interactions. In fibroblasts, Rho has been shown to regulate stress fiber formation, whereas Rac regulates membrane ruffling in response to serum stimulation . To date, two Rac proteins have been described in human: Racl has a ubiquitous expression pattern, and Rac2 is restricted to the hemopoietic cell lineage (Didsbury et al. 1989) . The functions of these molecules in morphogenesis in vivo are not known.
In this paper we report the characterization of two Drosophila genes, Dracl and Dcdc42. Both are expressed in the nervous system at the time of axonogenesis and in muscle precursors at the time of myoblast fusion. Expression of putative constitutively active or dominantnegative Dracl mutants in the nervous system or in mesoderm results in defective axon outgrowth or myoblast fusion, respectively. Expression of analogous Dcdc42 mutants generates morphological defects that are qualitatively distinct from those of the corresponding Dracl mutants. Thus, it appears that similar GTPases in the same subfamily have unique roles in morphogenesis in vivo.
Results

Cloning of Dracl and Dcdc42
We isolated first PCR fragments and then cDNAs encoding the entire open reading frame (ORF) of Dracl and Dcdc42 from a 0-to 12-hr Drosophila embryonic cDNA library {see Materials and methods). The Dracl nucleotide sequence predicts a 192-amino-acid protein with 92% sequence identity to human Racl and 89% identity to human Rac2. All of the essential features of the GTPases, including the nucleotide-binding pocket and the carboxy-terminal post-translational processing signal (Bourne et al. 1991} , are well conserved among Dracl and the two human Rac proteins. Most of the divergent sequences are near the carboxy-terminal "hypervariable" region (amino acids 180-185).
The Dcdc42 nucleotide sequence translates into a 191-amino-acid protein with 93% sequence identity to human Cdc42 (Cdc42Hs} and 79% identity to yeast Cdc42 (Cdc42Sc) (Fig. 1B) . The amino terminus is highly conserved among flies, human, and yeast. Most of the different amino acids reside in the carboxyl terminus. Dracl and Dcdc42 share 70% amino acid sequence identity (Fig. 1C) . Most of the differences reside in the last two-thirds of the proteins (amino acids . In the amino terminus there is one region of divergence (amino acids 26-56) that is flanked by well-conserved regions.
Expression of Dracl in embryogenesis
A single major transcript of 2.4 kb for Dracl and 2.3 kb for Dcdc42 was identified on a Northern blot of embryonic mRNA ( Fig. 2A, B) . Both transcripts were detected throughout development (data not shown). Strong and ubiquitous expression of Dracl RNA was evident in precellular (data not shown) as well as cellular blastoderm stages (Fig. 2C ). The transcript is concentrated at the basal part of cellular blastoderm (Fig. 2C ). After gastrulation, Dracl transcripts become highly enriched in mesoderm between stages 10 and 12 (staging according to Campos-Ortega and Hartenstein 1985; Fig. 2D ). At stage 13, Dracl transcripts start to appear in the nervous system and the gut (Fig. 2E) . Later in development, somatic mesoderm expression vanishes, whereas the nervous system and gut expression persists (Fig. 2F) . Interestingly, the expression pattern of Dcdc42 is qualitatively similar to that of Dracl in all of the stages described above (data not shown). This similarity cannot be caused by the cross-reactivity of the RNA probes (they share 60% identity in nucleotide sequences), because under the same condition, a probe from Drac2 (which shares 80% nucleotide sequence identity with the Dracl probe; see Materials and methods) labels predominantly the vis- Figure 1 . Amino acid sequences of Dracl and Dcdc42. The sequence at the top is the guide for comparison for sequences below. (:} Amino acid identity; divergent amino acids are indicated. ( -) Gaps introduced to maximize alignment. Numeration of the protein sequence begins with the initiation methionine and ends with the last codon before the stop codon. (A) Amino acid sequence of Dracl is aligned with those of human Racl (raclHs) and human Rac2 (rac2Hs). Dracl is 92% identical or 95% sirmlar to raclHs and 89% identical or 95% similar to rac2Hs. (Similarity is calculated assuming the following amino acids are conservative changes: A,S, and T; D, E, N, and Q; R and K; I, L, M, and V; F, Y, and W.) (B) Amino acid sequence of Dcdc42 is aligned with those of human (Cdc42Hs) and yeast (Cdc42Sc) Cdc42. Dcdc42 is 93% ceral mesoderm (data not shown). The expression of Dracl and Dcdc42 in the nervous system in stage 13 at the time of axonogenesis and in mesoderm at the time of muscle formation prompted us to investigate their roles in these processes.
Tissue-specific expression of dominant m u t a n t s as an experimental strategy to study the in vivo function of Dracl
The available information on constitutively active and dominant-negative mutants in Rac was employed to study Dracl function by expressing dominant mutants in a tissue-specific manner. This approach was taken not only because no mutants or chromosomal deletions of Dracl (at chromosomal location 61 F) were currently available but also because it circumvents the problem of potential pleiotropic effects of a Dracl mutant and the likely maternal rescue of the early phenotypes. Point mutations in three different positions of Dracl were generated--V12, N17, and L89. V12 (Val-12 for Gly-12) mutation was originally identified in an oncogenic form of Ras and later shown to render Ras constitutively active as a result of defective GTPase activity (for review, see Barbacid 1987) . N17 (Asn-17 for Thr-17) mutation was originally identified biochemically in Ras by its preferential binding to GDP relative to GTP (Feig and Cooper 1988) . RasN17 may function as a dominant-negative mutant by sequestering the rate-limiting guanine nucleotide exchange factor (Schweighoffer et al. 1993 ). More significantly, V12 and N17 mutations in h u m a n Racl, which shares 92% amino acid sequence identity with Dracl, were shown to work as constitutively active and dominant-negative proteins, respectively, in fibroblasts . 1:89 (Phe-89 for Set-89) mutation was identified in the ras homolog let60 of Caenorhabditis elegans that gives a dominant-negative phenotype in vulval development (Beitel et al. 1990; Han and Sternberg 1991) . It is hypothesized to work in a fashion similar to N17 (Han and Sternberg 1991) . We introduced each of these three mutations in Dracl individually, with the amino acid 89 position mutated from Ser to Leu instead of Phe. For simplicity, even though we do not have direct biochemical data on Dracl mutant proteins, we will refer to these mutants as constitutively active (V12) and dominant negative (N17 and L89)hereafter. The phenotypes generated by the coexpression of wild-type Dracl with the mutants are consistent with the above hypothesis (see Tables 1 and 2 , below).
To express the dominant mutants in a specific tissue or cell type, we used the GAL4 system recently established by Brand and Perrimon (1993) . We subcloned Dracl mutant genes into the pUAST vector and established transgenic lines. The pUAST vector contains the GAL4-responsive upstream activation sequence (UAS) and expresses the Dracl m u t a n t proteins only in the presence of GAL4. We then crossed these transgenic flies to flies that express GAL4 in either neurons or muscle precursors by specific promoters or enhancer traps (Brand and Perrimon 1993) . For all of the experiments shown below, at least two independent lines of pUAST GTPases were tested and were found to give similar re-Cold Spring Harbor Laboratory Press on October 28, 2017 -Published by genesdev.cshlp.org Downloaded from sults. The GAL4-induced expression of Dracl was verified by in situ hybridization (for an example, see Fig. 3H ).
Dracl m u t a n t s block axon outgrowth
To express Dracl in the nervous system, we used the GAL4 enhancer trap lines GAL4-1407 and GAL4-60. GAL4-1407 expresses the reporter gene early in neuroblasts (at stage 10/11) and subsequently in most neurons of the central nervous system (CNS), and in all neurons of the peripheral nervous system {PNS) (Fig. 3A-C) . GAL4-60 expresses the reporter in a subset of CNS neu- rons as well as all PNS neurons, with a later onset around stage 13 ( Fig. 3E-G) . We also constructed transgenic flies in which the neuronal-specific promoter from the gene elav (Robinow and White 1988; Yao and White 1994) drives GAL4 expression, elav-GAL4 expresses the reporter in all neurons in embryos starting at stage 12 (Fig. 3D) .
Expression of wild-type Dracl using the three nervous system GAL4 lines had no effect on embryonic viability (Table 1) . In contrast, expression of the three UASDracl mutants in the nervous system caused embryonic lethality to various extents (Table 1 ). In the most extreme case (GAL4-1407; UAS-DraclV12), all progeny are embryonic lethal.
To investigate the basis for embryonic lethality, we stained embryos generated from crossing homozygous GAL4 lines and homozygous UAS-Dracl mutants with monoclonal antibody 22C10 to visualize the general anatomy of the PNS. mAb22C10 labels all the cell bodies, dendrites, and axons of the PNS (Hartenstein 1988) .
Dracl in axonal outgrowth and myoblast fusion
In wild-type as well as in GAL4-1407;UAS-DraclWT (overexpressing wild-type Dracl proteins)embryos, each segment contains three highly stereotyped clusters of PNS neurons (Bodmer and Jan 1987; Hartenstein 1988) connected by axon bundles (Fig. 4A, arrows) .
When the dominant-negative DraclL89 was expressed with the GAL4-1407 line, we observed occasional loss of axons between the dorsal and lateral clusters (contributed by afferent axons of the dorsal cluster neurons) (Fig.  4B , short arrows; also see Table 2 ). Two copies of UASDraclL89 greatly increase the axonal loss (Table 2) . Coexpressing a UAS-DraclWT transgene ameliorates the axonal loss (Table 2) , which is consistent with L89 being a weak dominant-negative mutation. Expression of constitutively active DraclV12 with GAL4-1407 has a more severe axonal phenotype compared with that of DraclL89. In this case, we observed axonal loss between the dorsal and the lateral clusters in most segments (Fig .  4C , short arrows; Table 2 ). Sometimes the axons connecting the lateral and ventral clusters were also missing Homozygous GAL4 lines were crossed to homozygous UAS-Dracl wild-type or mutant lines, and embryos were collected on grape juice agar plates. Embryo cases were counted as hatched embryos 26-30 hr after egg laying (25~ Unhatched embryos were also counted, dechorionated, and observed for general structures and movement. Unfertilized eggs were discarded at this stage in calculating embryonic lethality rate. At least 100 embryos were used for each quantitation experiment. a(EL) Embryonic lethal; (ILL) first instar larval lethal; (LL) larval lethal. bViable adult means that some animals reach adulthood; no quantitation of percentage of viable adult was attempted. CGAL-24B; . I (coexpressing wild-type Drac 1 together with Dracl N 17) has a significantly higher embryonic viability rate (4.7 -+ 2.6%, mean + s.D.) than that of GAL-24B; UAS-DraclN17.1 (0.76 + 0.3%)(t-test, P < 0.005), thereby supporting the hypothesis that N17 acts as a dominant negative mutant. dNot determined.
Cold Spring Harbor Laboratory Press on October 28, 2017 -Published by genesdev.cshlp.org Downloaded from Figure 4 . Embryos expressing mutant Dracl in neurons exhibit axon outgrowth defects, as revealed by mAb 22C10 staining. (A) In a wild-type stage-16 embryo, mAb 22C10 stains segmentally repeated cell bodies of the PNS neurons of the dorsal and lateral clusters, their dendrites (arrowhead), and the axons connecting the dorsal and lateral clusters (long arrow). (B) In a GAL4-1407; UAS-Drac1L89 {two copies) embryo at stage 16, some of the axons that normally extend between lateral and ventral clusters are missing {short arrow) whereas dendrites of the dorsal external neurons {dorsal to the dorsal cluster neurons) and the bidendritic neurons (ventral-most of the dorsal cluster neurons) are present (arrowheads). {C)In a GAL4-1407;UASDracl V12 embryo at stage 15, the axons between the dorsal and the lateral clusters are missing in most segments {short arrow) whereas dendrites such as dorsal es dendrites (arrowhead) are still present. (D) In an elav-GAL4;UAS-Drac1V12 embryo at stage 16, axons between the dorsal and the lateral clusters are missing (short arrow) or stalled along the pathway in a few segments (asterisk) whereas dendrites are still present {arrow-heads). (E} A high magnification picture of the same embryo in D 14 • ) is shown. The growth cone of the stalled axon is clearly visible (* }. All embryos are shown from a dorsal-lateral view. Long arrows indicate the wild-type axons, short arrows designate the missing axons, and arrowheads represent the dendrites of the dorsal external sensory and bidendritic neurons.
{Fig. 4C, short arrow). Examination of mutant embryos at earlier stages suggests that no detectable axons were ever formed in the m u t a n t clusters {data not shown}.
We wonder whether Dracl mutant could also affect axon elongation in addition to initiation. We tested this by expressing DraclV12 using elav-GAL4, which has a later onset of GAL4 expression in the PNS. A small percentage of the axons between dorsal and lateral clusters were defective {Fig. 4D, short arrows~ Table 2 ). Axons from the dorsal cluster were often stalled along the pathway toward the lateral cluster. The growth cones of the stalled axons are clearly visible {Fig. 4E, asterisk}. These stalled axons are more likely to be permanently arrested than simply delayed, because in wild type the completion of the axons between dorsal and lateral clusters occurs well before the stages where these stalled axons can be found. Thus, in addition to affecting axon initiation, neuronal expression of Drac1V12 also affects axon elongation.
When UAS-DracI V12 is expressed under a later onset nervous system expression line GAL4-60, there is no detectable morphological defect m mAb 22C10 staining pattem (Table 2) , although 94% of the progeny die as embryos (Table 1} . This suggests that expression of Drac1V12 in the nervous system could interfere with other vital functions in addition to perturbing the initiation and elongation of axon outgrowth.
We found that although axonal outgrowth is affected in the presence of m u t a n t Dracl, other aspects of neuronal differentiation are not affected. Note that the number and position of mAb 22C10-staining cells remain the same as in wild-type embryos (Fig. 4} . In addition to mAb 22C10 antigen, other neuronal differentiation markers such as the horseradish peroxidase {HRP) antigen {Jan and Jan 1982} and the Drosophila synaptic vesicle-associated protein synaptotagmin (Littleton et al. 1993 )also appear in these axonless neurons (data not shown). Interestingly, the identifiable dendrites of the PNS neurons, such as those of the dorsal external sensory neurons ( Fig. 4B-D , arrowheads) and the dorsal bidendritic bAxons from dorsal clusters to the lateral clusters of abdominal segments A1-A7 were used for quantitation. Only the complete missing, occasionally stalled, or misrouting of the entire axon bundle were scored as axon defects. This is a stringent criterion, as it does not include apparent thinning of axon bundles in mutant embryos possibly due to the loss of axons from a subset of dorsal cluster neurons.
CTogether with the fact that 1407; UAS-Dracl V12 does not change any muscle phenotype revealed by MHC staining (data not shown), this experiment demonstrates the specificity of the GAL4 lines in generating the neuronal or muscle phenotypes.
neurons (Fig. 4B, arrowheads) , appear intact in these embryos.
Dracl V12 causes abnormal neuronal accumulation of F-actin
Because the Rac subfamily of GTPases have been implicated in membrane-actin cytoskeleton interaction, the mutant Dracl's phenotype may be accompanied by a defect in cytoskeleton. We studied the actin distribution in the PNS neurons by confocal microscopy using double labeling of mAb 22C10 and phalloidin. Filamentous actins (F-actins), as revealed by phalloidin staining, are enriched in growth cones of neurons (e.g., see O'Connor and Bentley 1993) . Consistent with this, we observed that CNS nerve tracks in developing embryos are heavily stained with phalloidin (data not shown). In wild-type embryos after stage 15, when the growth cones of PNS neurons already reached CNS, no strong phalloidin staining can be found in the dorsal cluster that overlaps with mAb 22C10 staining ( Fig. 5A-C) . In contrast, in GAL4-1407;UAS-DraclV12 embryos, the strongest phalloidin staining in the dorsal cluster (Fig. 5E , lines defined by the arrows) coincides with mAb 22C10 antigen (Fig. 5D, F) even at stage 16. The F-actin distribution in the dorsal cluster is not uniform; rather, it is accumulated in the ventral portion and appears to coincide with axon bundles within the dorsal clusters. Interestingly, in the mutant clusters of GAL4-1407; UAS-DraclL89 (two copies) embryo of the same stage, where no axons are visible between the dorsal and lateral clusters (in other focal planes), there is no accumulation of F-actin in the dorsal cluster as seen in GAL4-1407;UAS-DraclV12 embryos (Fig. 5G--I ). This suggests that the similar ax- No strong phalloidin staining coincides with the dorsal neuronal clusters, whereas the general phalloidin staining is similar to that of GAL4-1407; UAS-Dracl V12 (of. H with E).
onal-loss phenotypes generated by expressing constitutively active (V12) and dominant-negative (L89) Dracl mutants probably arise from different cytoskeletal defects in neurons.
Dracl mutants disrupt myoblast fusion
Because Dracl is predominantly expressed in mesoderm at stage 12 (Fig. 2D) , we investigated the function of Dracl in muscle development by expressing m u t a n t Dracl proteins under the control of a mesoderm line GAL4-24B. GAL4-24B expresses the reporter gene in most, if not all, of the mesoderm cells starting from stage 11 ( Fig. 3I, J ; Brand and Perrimon 1993) . Overexpression of wild-type Dracl has no effect on embryonic viability. However, expression of all three mutants with GAL4-24B causes embryonic lethality (Table 1 ) . Again, the V12 In wild-type embryos, after the completion of cell division and commitment to myogenic cell fate, myoblasts start to fuse at the end of stage 11 (Bate 1990) . When myoblast fusion is completed at stage 14, the multinucleated muscle cells begin to express muscle-specific markers such as muscle myosin heavy chain (MHC) (Kiehart and Feghali 1986;  Fig. 6A , B}. In GAL4-24B; UAS-Dracl V12 (constitutively active) embryos, MHC-positive cells retain segmentally repeated pattern as in wild-type, but myoblast fusion is completely blocked throughout somatic mesoderm in all stages exarnined ( Fig. 6C, D; data not shown) .
Expression of the dominant-negative DraclN17 and L89 mutants delays myoblast fusion initially and then causes excessive fusion. At stage 14 we found many MHC-positive cells with single nuclei in embryos expressing either mutant ( Fig. 6G ; data not shown). At later stages there are significantly fewer MHC-expressing cells in GAL4-24B;UAS-DraclN17 embryos (Fig. 6I , J}. The remaining MHC-positive cells form thin fibers that do not resemble the wild-type pattern. Novel cruciformshaped fibers, most likely resulting from the fusion of horizontal and vertical muscle fibers, are formed (Fig. 6J,  bracketed) . Even though most of the fibers occupy close to wild-type position (Fig. 6E,F) , GAL4-24B;UASDraclL89 embryos also exhibit cruciform-shaped fusions in the lateral clusters (data not shown), excessive fusion in the ventral-most region (Fig. 6F, bracketed) , as well as abnormal fusion involving the ventral-most muscles from the left and the right hemisegments across the midline (Fig. 6H, open arrows) . These excessive fusions were never observed in wild type.
Similar to what we found in the nervous system, Dracl also appears to affect only a specific aspect of muscle differentiation. Even though fusion is completely inhibited, GAL4-24B;UAS-DraclV12 embryos still express muscle-specific B3-tubulin transcripts (Leiss et al. 1988 ) at stage 15 (Fig. 7, cf. B with A) , and the cell surface adhesion protein connectin (Nose et al. 1992; Meadows et al. 1994) in similar positions as in wild-type at stage 13 (Fig. 7 , cf. D with C) and at later developmental stages {Fig. 7, cf. F with E). The correct regional distribution of connectin in the mutant embryos (Fig. 7C-F) suggests that DraclV12 expression does not affect either the overall muscle pattern or muscle-specific gene expression.
Dcdc42 mutants cause distinct morphological defects in neurons and muscles
We wondered whether dominant Dracl phenotypes reflected the normal function of the wild-type Dracl protein. An alternative possibility would be that the dominant Drac 1 proteins are interfering with the functions of other related GTPases by competing for limiting factors such as exchange factors or effectors. To test this we took advantage of the fact that Dcdc42 has a similar expression pattern and is 70% identical to Dracl (Among all identified GTPases, the only one that is more similar to Dracl than Dcdc42 is Drac2, which has a different expression pattern). We reasoned that if we were merely perturbing the function of small GTPases in general, analogous mutants V12 and N17 of Dcdc42 would have similar phenotypes as those of Dracl mutants. Conversely, if the phenotypes were distinct, then the two GTPases would be likely to play distinct roles and the dominant phenotypes generated would reflect the wildtype functions.
We found that expressing constitutively active Dcdc42 in the nervous system (GAL4-1407;UAS-Dcdc42V12) resulted in 100% embryonic lethality (Table 1) , similar to expressing the analogous mutation in Dracl. However, the PNS neuronal morphology, as revealed by mAb 22C10 staining, is qualitatively distinct (Fig. 8A, B) . Unlike wild-type and Dracl mutants which contains elongated dorsal clusters (Fig. 4) , GAL4-1407;UASDcdc42V12 embryos tend to form shorter and rounder dorsal clusters (Fig. 8B) . Not only are axons missing between dorsal and lateral clusters in a subset of the segments (Table 2) , the dendrites (such as the dorsal external sensory dendrites; Fig. 8A , arrowheads) also tend to be abnormal or absent (Fig. 8A, open triangles) . Compared with Drac 1V 12 mutants, expressing Dcdc42V 12 in the nervous system seems to have a more general effect, including neuronal position and dendrite as well as axon outgrowth.
Unlike GAL4-24B;UAS-DraclVI2, most of the GAL4-24B;UAS-Dcdc42V12 embryos (expressing constitutively active Dcdc42 in mesoderm) are mobile at later stages and a small percentage hatches (Table 1) . The muscle fibers in these animals, as revealed by MHC antibody staining, are clearly abnormal in shape (Fig. 8C,D , arrows). They tend to form spindle, rather than the tubular, fibers in wild type (Fig. 6A, B) . The muscle pattern is also not entirely normal (Fig. 8C,D, cf. with Fig. 6A, B) . In sharp contrast with the analogous mutants of Dracl, which results in complete failure of myoblast fusion (Fig. 6C, D) , almost all MHC-positive cells in GAL4-24B; UAS-Dcdc42V12 embryos are multinucleated (Fig.  8D) , indicating that myoblast fusion is not affected. In GAL4-24B; UAS-Dcdc42N17 (dominant-negative) embryos the muscle fibers are mostly wild type (Fig. 8E) , with subtle defects in certain segments (Fig. 8F, open  arrows) . Again, this is in contrast with the analogous mutant in Dracl, which causes severe fusion defects (Fig. 6G,I,J) . In summary, we found that expression of constitutively active and dominant-negative Dcdc42 mutants cause phenotypes in both the nervous system and muscle that are qualitatively different from those of the corresponding Dracl mutants.
Discussion
In this paper we present evidence that expression of constitutively active or dominant-negative Dracl proteins in neurons and muscle precursors perturbs axon outgrowth and myoblast fusion, respectively. Expressing the analogous mutants of a highly related GTPase, Dcdc42, causes qualitatively different phenotypes. At this point we cannot rule out the possibility that the dominant mutants of these GTPases affect the activity of other Connectin is expressed on the cell surface of a subset of myoblasts that occupy the same position in wild-type (C) and GAL4-24B; UAS-Dracl V12 embryos (D) just before fusion at stage 13. At stage 15, connectin is expressed on the surface of several lateral and ventral muscle fibers in wild type (E) and in corresponding positions in GAL4-24B; UAS-Dracl V12 unfused myoblasts (F). C-E are lateral views, and F is a ventral-lateral view. (lm) lateral muscles; (vm) ventral muscles; (vnc) ventral nerve cord; (t) thoracic segment; {a) abdominal segment.
unidentified GTPases. Nevertheless, the distinct phenotypes of Dracl and Dcdc42 dominant mutations suggest that the mutant proteins do not simply perturb GTPases in general but rather affect the activity of the wild-type counterparts with some specificity and that we can infer from the mutant phenotype the wild-type function of the proteins. Accordingly, we suggest that Dracl is involved in specific aspects of neuronal and muscle morphogenesis, particularly axon but not dendrite outgrowth, and myoblast fusion. In contrast, Dcdc42 appears to be involved in more general aspects of morphogenesis and patterning in both cell types.
Dracl functions in morphogenesis
The phenotypes generated by expressing mutant Dracl in neurons and muscles can be interpreted in two ways. First, Dracl may be involved in the signaling process leading to the differentiation of these cell types. For instance, the small GTPase Ras has been shown in both vertebrates and invertebrates to be involved in such a differentiation signaling pathway (Bar-Sagi and Feramisco 1985; Beitel et al. 1990; Simon et al. 1991) . Alternatively, Dracl could participate in executing the morphogenetic process after the differentiation signal has been properly received and interpreted.
Several lines of evidence indicate that Dracl plays the latter function in both the nervous and the muscle systems. First, the number, location, and pattern of mAb 22C10-or MHC-staining cells are not changed in mutant embryos (except in the late stage of muscle development in GAL4-24B; U A S -D r a c l N 1 7 embryos). Second, molecules that are only associated with differentiated neurons or muscles, such as the mAb 22C10 antigen (Fig. 4) , the HRP antigen, and synaptotagmin (data not shown) in neurons and MHC (Fig. 6 ), ~3-tubulin (Fig. 7A, B) , and (Fig. 4) . Arrowheads and arrows indicate dendrites and axons that are approximately wild type, whereas triangles indicate the defective dendrites. For this particular embryo only one segment is completely missing the axons between the dorsal and lateral cluster after viewing at different focal planes (see Table 2 for the quantitation). (C,D) MHC staining of two stage-16 GAL4-24B; UAS-Dcdc42VI2 embryos (ventral views, 4x magnified in D) reveals the abiaormal morphology of the muscle fibers. The muscle fibers tend to be broader and shorter, and the patterns are not entirely normal compared with wild type (Fig. 6A, B) . However, almost all MHC-positive cells are multinucleated {arrow in D). (E,F) MHC staining pattern of two stage-16 GAL4-24B;UAS-Dcdc42NI7 embryos {ventral lateral view, 4x magnified in F) is nearly normal. Occasional narrow and abnormal fibers can be observed in the ventral-most muscles {open arrows in F, cf. to wild type in Fig. 6B ). Short arrows in C and E point to the ventral midline.
connectin (Fig. 7C-F) in muscles are still present in the embryos expressing m u t a n t D r a c l proteins. In contrast, expressing V12 m u t a n t of Ras in the m a m m a l i a n C2 muscle cell line completely blocks myoblast fusion as well as M H C and other muscle-specific gene expression (Olson et al. 1987 ). Third, a certain degree of morphological differentiation does occur in embryos expressing m u t a n t Dracl. In the nervous system, although the axons are missing, the dendrites are still present. A l t h o u g h it remains possible that the relatively late onset of the transgene expression prevented us from perturbing Dracl's function in the differentiation signaling process, if there is any, our results certainly indicate that Dracl plays a significant role in morphogenesis.
Implication for neuronal morphogenesis
Although neurons are highly polarized cells and dendrites are clearly different from axons in morphology, cytoskeleton components, membrane protein, and lipid distribution and functions, the mechanism that generates this polarity is not well understood (Craig and Banker 1994) . This problem has been mainly studied using primary cultured neurons (Dotti et al. 1988 ). In the cell culture system it has been shown in antisense inhibition experiments that the microtubule-associated proteins Tan and MAP2 are essential for axons and minor processes, respectively (Caceres and Kosik 1990; Caceres et al. 1992) .
Our experiments provide an in vivo demonstration that the dominant mutations in Dracl can perturb the establishment of neuronal asymmetry--the initiation and elongation of axon outgrowth. Expressing mutant Dracl seems to have a specific effect on axons but not dendrites. This indicates--in contrast to the development of axon/dendrite polarity in cultured cells (Dotti et al. 1988 )~that even in the earliest stage of neuronal differentiation in the developing fly embryo, the axon/dendrite asymmetry is already established. Dracl probably participates in such a decision. The fact that mutant Dcdc42 affects both dendrites and axons also supports a specific role for Dracl in axon outgrowth.
The Rac/Rho/Cdc42 subfamily of GTPases is implicated in the actin cytoskeleton membrane interaction . On the other hand, actin cytoskeleton has been shown to be important for axon initiation, filopodia formation, and axon navigation (Bentley and Toroian-Raymond 1986; Forscher and Smith 1988; Lefcort and Bentley 1989) . Our results that mutant Dracl blocks axon initiation and elongation tie these previous findings together. Furthermore, expressing constitutively active DraclV12, but not dominant-negative DraclL89, mutant in neurons causes abnormal F-actin distribution (Fig. 5) . This experiment suggests an explanation for the apparent paradox that expression of the constitutively active and dominant-negative Dracl mutants results in similar morphological phenotype. It argues against the possibility that abnormal F-actin accumulation in the neuronal cluster is a mere consequence of abnormal axon outgrowth, and it supports the view that regulated actin polymerization is important for axonal outgrowth. The constitutively active and dominant-negative Dracl mutants may block the regulation in different steps, resulting in similar morphological consequences.
Implications for muscle morphogenesis
Myogenesis has been used extensively as a model for studying mammalian cell differentiation largely because of the convenient and well-established cell culture system (Blau et al. 1983) . Over the last several years, key myogenic genes of the basic helix-loop-helix family of transcription factors have been isolated. They are responsible for activating the myogenic program such as the expression of muscle-specific proteins and the myoblast fusion both in cell culture and in vivo (for review, see Weintraub 1993) . The mechanisms to carry out the morphogenetic events leading to mature muscle formation--myoblast fusion being an essential step---are poorly understood.
In Drosophila, embryonic muscle pattern formation has been studied extensively in recent years (for review, see Bemstein et al. 1993) . Genetic and anatomical analyses of muscle development (Bate 1990; Dohrmann et al. 1990; Michelson et al. 1990 )have led to the hypothesis that for every muscle fiber there is a founder cell. Other fusion-competent cells will fuse with the founder cell to form patterned muscle fibers (Bate 1990) . Thus, the patterning information could be encoded by the specification of founder cells. In addition, fusion-competent cells must know to which founder cell they should fuse.
When Dracl mutant proteins are expressed in the muscle precursors, myoblasts fail to fuse properly. This could be hypothesized as the result of the change of cell fate of the founder cells so that they no longer are able to fuse with the fusion-competent cells. Alternatively, Dracl may be directly involved in regulating the fusion process itself. We favor the latter possibility because (1) Dracl is expressed ubiquitously in somatic muscle precursors (Fig. 2B) , and (2) expression of dominant-negative Dracl generates excessively fused muscle fibers in later developmental stages; such excessively fused muscle fibers can be interpreted as an opposite phenotype as the lack of fusion caused by expression of constititively active Dracl.
Cell adhesion has been shown previously to be important for myoblast fusion (Knudsen et al. 1990a, b; Rosen et al. 1992) . Our results implicate the involvement of an intracellular small GTPase known to affect actin cytoskeleton in the regulation of fusion, suggesting that there is potential link between the two systems.
Distinct roles in morphogenesis by highly related GTPases
The qualitatively different phenotypes generated by expressing dominant Dcdc42 mutants in neurons and muscles not only serve as controls for the specificity of Drac l's effect but also offer insight into the in vivo function of Dcdc42 itself. In neurons, Dcdc42 seems to affect a more general aspect of morphogenesis, including cell positioning, which might be a consequence of abnormal cell migration, and dendrite as well as axonal outgrowth. In muscles, Dcdc42 affects the shape and pattern of the muscle fibers, which might also be an indirect consequence of myoblast not migrating to the correct position before fusion. We suggest that in addition to affecting cell division in budding yeast, this phylogenetically highly conserved GTPase also plays a role in the mor-Cold Spring Harbor Laboratory Press on October 28, 2017 -Published by genesdev.cshlp.org Downloaded from phogenesis of different cell types in multicellular organisms.
Dcdc42 shares 70% amino acid sequence identity with Dracl. The fact that the constitutively active (V12) mutants give mostly nonoverlapping phenotypes {with the exception that both seem to affect axon outgrowth in neurons} implies that they can distinguish their distinct effectors with precision. Another interesting point is that two different putative dominant-negative mutations seem to have differential effects in different tissues. In muscle, DraclN17 mutation has a stronger phenotype than DraclL89, whereas in neurons DraclL89 causes axon loss while no detectable morphological phenotype could be observed with Drac 1N 17.
Rho, Rac, and Cdc42 exhibit high sequence similarity and fall into the same subfamily of small GTPases implicated in actin cytoskeleton organization in fibroblast {Ridley and Hall 1992; and bud site assembly in yeast (Drubin 1991 J. In this study we extend the biological function played by this class of molecules into the development of multicellular organisms and show that these similar GTPases may play distinct roles in morphogenesis in vivo. Dracl is specifically involved in axonal outgrowth in neurons and in myoblast fusion in muscle. Because neither of these processes is well understood in mechanistic terms, our findings open up a way to further dissect both of these processes using Drosophila genetics.
Kauvar cDNA library made from 0-to 12-hr Drosophila embryos. For Dracl, a 1.7-kb cDNA containing the entire ORF was isolated and cloned into Bluescript as an EcoRI fragment. It has about a 300-bp 5'-untranslated region (5' UTR) and an 800-bp 3'-untranslated region (3' UTR). For Dcdc42, a 1.65-kb cDNA was identified that contains the entire ORF, a 180-bp 5' UTR, and -850-bp 3' UTR. The nucleotide sequences encompassing the ORF of both genes were determined by sequencing the cDNAs from both directions using oligonucleotides as primers.
Site-directed mutagenesis and DNA constructs
Dracl and Dcdc42 cDNAs in Bluescript were used as templates for site-directed mutagenesis with Amersham's in vitro mutagenesis system (Nakamaye and Eckstein 1986) . Mutations were confirmed by DNA sequencing. Wild-type and mutant Dracl and Dcdc42 cDNAs were then digested with EcoRI and inserted into the polylinker of the transformation vector pUAST (Brand and Perrimon 1993) .
For the generation of the elav-GAL4 construct, first the SV40 poly(A} trailer from pUAST was cloned into Bluescript (SK-) NotI and BamHI sites. The above construct was cut with SacII, blunt-ended with T4 DNA polymerase, cut with NotI, and ligated to a 3.5-kb EcoRV-NotI-digested fragment that contains the promoter region of the Drosophila gene elav. The construct generated above was digested at the NotI site between the elav promoter and the SV40 poly(A) and ligated to a NotI fragment containing the GAL4-coding region derived from the HindIII fragment of the vector pGATN (Brand and Perrimon 1993) . The construct then was digested with EcoRI and inserted into the transformation vector CaSpeR (Pirrotta 1988 ).
Materials and methods
Cloning of Dracl and Dcdc42
Two primer pairs were used for reverse transcription-PCR amplification. The first pair [forward: 5'-GA(C/T)ACIGCIGGI-CA{A/G}GA(A/G)GAITA-3'; reverse: 5'-ATIGC(T/C)TC(A/ G)TC(A/G}AAIACIIG/TJT-3'] corresponds to a region common to human and yeast Cdc42 as well as their closest relatives (Shinjo et al. 1990 ), human Racl and Rac2 (amino acids 57-64 and 168-173 of Cdc42/Rac}. The second pair [forward: 5'-AA(C/ T)TAIC/T)GCIGTIACIGTIATGATIA/C/T)GG-3'; reverse: 5'-ATIGC{T/C)TC(A/G)TC(A/G)AAIACI(G/T]T-3'I is specific for yeast and human Cdc42 [amino acids 39-47 and 150-157} (Shinjo et al. 1990} . Total RNA was prepared from 4-to 12-hr Drosophila embryos (Jowett 1986} and used as template for RT-PCR using Invitrogen's cDNA Cycle Kit. PCR conditions were 94~ 3' for denaturation, followed by 40 cycles of 94~ for 1 min, 45~ for 1 rain, and 72~ for 3 min, and ended by 72~ for 7 min. PCR products were subcloned by blunt-end ligation into Bluescript plasmid [Stratagene), digested with EcoRV and subjected to double-stranded DNA sequencing according to standard protocol (Sequenase kit, U.S. Biochemical}.
Two very similar genes, Dracl and Drac2, were identified by PCR with the first pair of oligonucleotides. The PCR fragments encode two polypeptides that share 92% amino acid sequence identity. We focused on Dracl for further studies because it is expressed in muscle precursors during muscle differentiation and in the nervous system during axonogenesis. In contrast, Drac2 is highly enriched in the visceral mesoderm. A single gene, Dcdc42, was identified with the second pair of the primers.
The PCR products of Dracl and Dcdc42 were digoxigeninlabeled {Boehringer Mannheiml and used as probes to screen the
Germ-line transformation and genetics
Germ-line transformation was performed according to standard procedure [Spradling and Rubin 1982} . Transformants with w + eye color were mapped and homozygosed with the help of a double balancer stock w;T(2;3)Ata/CyO;Tm3Sb. To look for phenotypes generated by expressing mutant Dracl and Dcdc42 in different tissues, we crossed homozygous GAL4 lines {1407, 60, elav-GAL4, and 24B) to homozygous UAS-Dracl and UASDcdc42, respectively, so that 100% embryos are of the same genotype.
In situ hybridization and immunocytochemistry
Digoxigenin-labeled RNA probes were used for embryo in situ hybridization according to methods described previously (Tautz and Pfeifle 19891 . For HRP-immunocytochemistry, embryo fixation was done according to methods previously described {Bod-mer and Jan 1987}. After devitellinization, embryos were rehydrated in 0.1 M phosphate buffer (pH 7.2J with 0.1% Triton X-100 {PBT} and blocked with 5% normal goat serum for onehalf hour at room temperature. All primary antibody incubations were done at 4~ ovemight with the specific conditions listed below. Rabbit anti-B-galactosidase (Cappell, preabsorbed against 0-to 17-hr embryos, (1:5000}; goat anti-HRP (Cappel) (1:1000]; mAb 22C10 (Fujita et al. 1982 ; gift from S. Benzer) (1:1501; rabbit anti-synaptotagmin (Littleton et al. 1993 , gift from J.T. Littleton and H. Bellen}, preabsorbed against 0-to 9-hr embryos [1:5001; rabbit anti-MHC {Kiehart and Feghali 1986, gift from D. KiehartJ {1:500); mouse anti-connectin monoclonal (Meadows et al. 1994 , gift from R. White}, preabsorbed against 0-to 9-hr embryos (1:10}. Anti-13-galactosidase and anti-MHC antibody stainings were amplified with Vectastain ABC kit according to manufacturer's specifications. The rest were recog-nized by secondary antibody conjugated with HRP (Bio-Rad). The stainings were developed in 100 mM Tris (pH 7.5)with 0.2 mg/ml of diaminobenzidine and 0.06% H20 2.
Phalloidin staining and confocal microscopy
For double labeling with mAb 22C10 and phalloidin, dechorionated embryos were fixed in 5% formaldehyde/heptane for 1 hr. The embryos were transferred to double-stick tape and devitellinized manually with a 25-gauge needle in a dish containing PBT. They were then processed for antibody staining as usual. During secondary antibody incubation (1:200 DTAF conjugated donkey-anti-mouse; Jackson Laboratory), 1 ~xg/ml of phalloidin-Texas red (Sigma) was added. The samples were mounted in 80% glycerol with 2% propyl gallate and viewed with an MRC-600 confocal microscopy. Images were processed with Altimira Composer and Photoshop programs.
